Professor Robin Feldman is quoted in a Business Insider article entitled “How the Supreme Court rules on a seemingly obscure case could have a huge impact on prescription drugs.”

Tweet about this on TwitterShare on LinkedInShare on FacebookShare on Google+Email this to someone

“‘In patent law, much turns on the nitty-gritty details. There’s nothing grittier than the issue’ raised in the Supreme Court case, Robin Feldman, a law professor at the University of California, Hastings, told STAT. ‘It matters a lot. It matters a lot for pharma.’”

The full article can be viewed here.

Tweet about this on TwitterShare on LinkedInShare on FacebookShare on Google+Email this to someone

Comments are closed.